000 | 01477 a2200421 4500 | ||
---|---|---|---|
005 | 20250513175216.0 | ||
264 | 0 | _c19990429 | |
008 | 199904s 0 0 eng d | ||
022 | _a0304-3835 | ||
024 | 7 |
_a10.1016/s0304-3835(98)00388-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGagandeep, S | |
245 | 0 | 0 |
_aPaclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines. _h[electronic resource] |
260 |
_bCancer letters _cFeb 1999 |
||
300 |
_a109-18 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aKidney Tubules _xdrug effects |
650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
650 | 0 | 4 |
_aThymidine _xmetabolism |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aVerapamil _xpharmacology |
700 | 1 | _aNovikoff, P M | |
700 | 1 | _aOtt, M | |
700 | 1 | _aGupta, S | |
773 | 0 |
_tCancer letters _gvol. 136 _gno. 1 _gp. 109-18 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0304-3835(98)00388-7 _zAvailable from publisher's website |
999 |
_c10171186 _d10171186 |